Martin Vollmer, biopharma program manager at Agilent Technologies, spoke to LCGC International about the evolving importance of glucagon-like peptide-1 (GLP-1) therapeutics and the challenges they ...

Imagine a bacterial cell—one of the multi-drug-resistant varieties that keep infectious disease experts up at night—blown ...

Follistatin-344 peptide has garnered significant attention in scientific research due to its intricate interactions with ...

This technique allows one to substitute a Cys for a native Ala residue during peptide synthesis (for use in ligation) and then convert the Cys back to the native Ala following ... The synthetic l - ...

Peptides are traditionally synthesized through the use of SPPS (solid-phase peptide synthesis). When scale-up is required for high-volume demand, this approach may not be feasible. In this case, the ...

Peptides are traditionally synthesized through the use of SPPS (solid-phase peptide synthesis). When scale-up is required for high-volume demand, this approach may not be feasible. In this case, the ...

Disulfide-constrained peptides (DCPs) have gained increased attention as a drug modality due to their exceptional stability and combined advantages of large biologics and small molecules. Chemical ...

In recombinant peptide synthesis, the DNA sequence encoding the desired peptide is inserted into the genetic material of a host organism. Typically incorporated into a plasmid or other vector, this ...

Aurisco's modern R&D labs develop synthetic and recombinant peptides and oligonucleotides. Aurisco Pharmaceutical's manufacturing facility in Yangzhou passed a USFDA inspection in August 2023 and ...